Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Mannitol could lead to new approach for Parkinson's disease treatment, researchers suggest

Researchers from Tel Aviv University describe experiments that could lead to a new approach for treating Parkinson's disease using a common sweetener, mannitol.

8 Apr 2013

Patent covering methods of treating ALS receives notice of allowance

Neuralstem, Inc. announced today that it received a notice of allowance for patent application 12/404,841. This patent covers methods for treating amyotrophic lateral sclerosis (ALS or Lou Gehrig 's disease) with expanded spinal cord stem cells, including NSI-566.

6 Apr 2013

Study applying OPKO Health's technology to identify synthetic peptoid in NMO patient serum published

OPKO Health, Inc. today announced the publication of a study applying its novel library screening technology to identify a synthetic peptoid that binds to anti-Aquaporin 4 antibodies in the serum of patients with Neuromyelitis optica.

6 Apr 2013

Studies, search for genetic risk factors needed to predict individual's risk for traumatic brain injury

One of the most controversial topics in neurology today is the prevalence of serious permanent brain damage after traumatic brain injury. Long-term studies and a search for genetic risk factors are required in order to predict an individual's risk for serious permanent brain damage, according to a review article published by Sam Gandy, MD, PhD, from the Icahn School of Medicine at Mount Sinai in a special issue of Nature Reviews Neurology dedicated to TBI.

6 Apr 2013

New technology provides clear images of brain with Parkinson's without use of intrusive restraints

A technology being developed at Oak Ridge National Laboratory promises to provide clear images of the brains of children, the elderly and people with Parkinson's and other diseases without the use of uncomfortable or intrusive restraints.

5 Apr 2013

Animal robots for dementia treatment: an interview with Professor Wendy Moyle, Griffith University

A robotic cat was first trialled in the US in early 2004 as a companion pet for people with dementia. A number of nursing homes have either ‘toy’ or robotic animals that they use as entertainment for older residents as well as people with dementia.

5 Apr 2013

Researchers conduct screening trial to weigh benefits, risks of routine screening for dementia

Researchers from the Indiana University Center for Aging Research and the Regenstrief Institute are conducting the nation's first randomized controlled dementia screening trial to weigh the benefits and risks of routine screening for dementia.

5 Apr 2013

Dementia care costs top other diseases in US, study finds

The costs of caring for people with dementia in the U.S. are comparable to - if not greater than - those for heart disease and cancer, according to new estimates by researchers at the University of Michigan Health System and nonprofit RAND Corporation.

5 Apr 2013

Dementia's price tag can exceed $50,000 a year, study finds

The study, published in the April 3 edition of the New England Journal of Medicine, found this medical condition costs the nation as much as $215 billion a year.

5 Apr 2013

Researchers identify new set of genetic markers for Alzheimer's

Researchers at Washington University School of Medicine in St. Louis have identified a new set of genetic markers for Alzheimer's that point to a second pathway through which the disease develops.

5 Apr 2013

TSRI scientists identify new drugs for human prion disease

Human diseases caused by misfolded proteins known as prions are some of most rare yet terrifying on the planet—incurable with disturbing symptoms that include dementia, personality shifts, hallucinations and coordination problems.

4 Apr 2013

First Edition: April 4, 2013

Kaiser Health News staff writer Julie Appleby, working in collaboration with USA Today, reports: "It's not just sore throats and flu shots anymore. Walgreens today became the first retail store chain to expand its health care services to include diagnosing and treating patients for chronic conditions such as asthma, diabetes and high cholesterol. The move is the retail industry's boldest push yet into an area long controlled by physicians, and comes amid continuing concerns about health care costs and a potential shortage of primary care doctors" (Appleby, 4/4).

4 Apr 2013

Researchers use brain-imaging tool and stroke risk assessment to detect signs of cognitive decline

UCLA researchers have used a brain-imaging tool and stroke risk assessment to identify signs of cognitive decline early on in individuals who don't yet show symptoms of dementia.

4 Apr 2013

Schizophrenia patients experiencing relapse are more likely to develop UTIs

Schizophrenia patients experiencing relapse are 29 times more likely than healthy individuals to have a urinary tract infection, researchers report.

4 Apr 2013

Noven Pharmaceuticals files ANDA with FDA for approval of generic version of Exelon

Noven Pharmaceuticals, Inc. today confirmed that it has filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking approval to market its rivastigmine transdermal system in 4.6 mg/24 hours and 9.5 mg/24 hours dosage strengths.

4 Apr 2013

Obama rolls out $100M initiative to study the brain

President Obama revealed a $100 million plan Tuesday to study and better understand the human brain in part to attempt to find better treatments for Alzheimer's and other diseases.

4 Apr 2013

First Edition: April 3, 2013

Today's headlines include reports about how the latest round of payment rates for private Medicare plans led to stock market gains for insurers.

3 Apr 2013

Research facilitates development of treatments, cures to Alzheimer's disease

A team of researchers at The New York Stem Cell Foundation Research Institute led by Scott Noggle, PhD, Director of the NYSCF Laboratory and the NYSCF - Charles Evans Senior Research Fellow for Alzheimer's Disease, and Michael W. Nestor, PhD, a NYSCF Postdoctoral Research Fellow, has developed a technique to produce three-dimensional cultures of induced pluripotent stem cells called embryoid bodies, amenable to live cell imaging and to electrical activity measurement.

3 Apr 2013

Risk prediction tools that estimate future risk of stroke and heart disease may also predict memory loss

Risk prediction tools that estimate future risk of heart disease and stroke may be more useful predictors of future decline in cognitive abilities, or memory and thinking, than a dementia risk score, according to a new study published in the April 2, 2013, print issue of Neurology®, the medical journal of the American Academy of Neurology.

2 Apr 2013

MIT scientists model structure of alpha synuclein protein associated with Parkinson's

Clumps of proteins that accumulate in brain cells are a hallmark of neurological diseases such as dementia, Parkinson's disease and Alzheimer's disease. Over the past several years, there has been much controversy over the structure of one of those proteins, known as alpha synuclein.

2 Apr 2013

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Mannitol could lead to new approach for Parkinson's disease treatment, researchers suggest

Patent covering methods of treating ALS receives notice of allowance

Study applying OPKO Health's technology to identify synthetic peptoid in NMO patient serum published

Studies, search for genetic risk factors needed to predict individual's risk for traumatic brain injury

New technology provides clear images of brain with Parkinson's without use of intrusive restraints

Animal robots for dementia treatment: an interview with Professor Wendy Moyle, Griffith University

Researchers conduct screening trial to weigh benefits, risks of routine screening for dementia

Dementia care costs top other diseases in US, study finds

Dementia's price tag can exceed $50,000 a year, study finds

Researchers identify new set of genetic markers for Alzheimer's

TSRI scientists identify new drugs for human prion disease

First Edition: April 4, 2013

Researchers use brain-imaging tool and stroke risk assessment to detect signs of cognitive decline

Schizophrenia patients experiencing relapse are more likely to develop UTIs

Noven Pharmaceuticals files ANDA with FDA for approval of generic version of Exelon

Obama rolls out $100M initiative to study the brain

First Edition: April 3, 2013

Research facilitates development of treatments, cures to Alzheimer's disease

Risk prediction tools that estimate future risk of stroke and heart disease may also predict memory loss

MIT scientists model structure of alpha synuclein protein associated with Parkinson's

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Newsletters you may be interested in